The efficiency and success of contrast agent production in the pharmaceutical industry are intrinsically linked to the quality of the raw materials used. Among these, 5-Amino-2,4,6-triiodoisophthaloyl Acid Dichloride (ATIPA), identified by CAS number 37441-29-5, stands out as a critical intermediate. Its unique chemical structure makes it an indispensable component in the synthesis of advanced iodinated contrast media, vital for diagnostic imaging.

As a leading manufacturer and supplier of fine chemicals, our focus is on delivering intermediates that meet the rigorous demands of the pharmaceutical sector. Our ATIPA is produced with a guaranteed minimum purity of 98.0% (HPLC), a specification crucial for ensuring the optimal performance and safety of the final contrast agents. This commitment to quality is supported by our substantial production capacity, reaching 200 metric tons per year, which allows us to provide a consistent and reliable supply for our global clientele.

For companies looking to buy 5-amino-2,4,6-triiodoisophthaloyl acid dichloride, understanding the benefits of partnering with an experienced supplier is paramount. We offer comprehensive support, including readily available Certificates of Analysis (CoA) and HPLC data, which are essential for quality assurance and regulatory compliance. These documents provide critical insights into the product’s purity and characteristics, facilitating smoother integration into your manufacturing processes.

The chemical synthesis of contrast agents involves complex reactions where the purity of intermediates like ATIPA directly influences the yield and quality of the end product. Our competitive price strategy, coupled with our manufacturing expertise, makes us an attractive option for pharmaceutical companies worldwide. We aim to streamline the procurement process, ensuring that you can secure this vital building block without compromising on budget or quality standards.

The role of ATIPA extends beyond just being an ingredient; it is a key enabler of advanced medical diagnostic technologies. By ensuring a stable and high-quality supply of this intermediate, we contribute to the consistent production of effective contrast agents that aid clinicians in diagnosing a wide range of medical conditions. We encourage R&D professionals and procurement specialists to connect with us to explore how our reliable supply and quality assurance can optimize your contrast agent production.